Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Wilterding currently holds 25,049 shares of RxSight, Inc. (RXST), valued at approximately $0. This represents their equity stake as Chief Financial Officer.
Based on SEC Form 4 filings, Mark Wilterding has been a net seller of RXST stock. They have purchased $0 and sold $54.0K worth of shares.
Mark Wilterding's most recent insider trade was on Sep 2, 2026, when they sold 7,765 shares at $6.96 per share.
Mark Wilterding serves as Chief Financial Officer at RxSight, Inc. (RXST). They have executed 3 insider transactions totaling $54.0K over their tenure at the company.
Mark Wilterding holds the position of Chief Financial Officer at RxSight, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Mark Wilterding has shown a selling trading pattern, with $0 in total purchases and $54.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Wilterding was on Sep 2, 2026, when they sold $54.0K worth of RXST shares. This transaction involved 7,765 shares at $6.96 per share.
Mark Wilterding currently owns 25,049 shares of RxSight, Inc. (RXST), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Wilterding's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Wilterding has 3 Form 4 filings on record as an insider at RxSight, Inc..
Set alerts for Mark Wilterding and 40,000+ other insiders.